Poster Presentation Australasian Diabetes in Pregnancy Society Annual Scientific Meeting 2024

A Case of Severe Gastroparesis in Pregnancy (#6)

Abigail K L'Amie 1 2 3 4 , Joey Yeoh 3 4 , Heena Lakhdhir 4
  1. Women's Health, National Women's Hospital/ Auckland City Hospital, Auckland , New Zealand
  2. Endocrinology & Diabetes, Greenlane Clinical Centre, Auckland , New Zealand
  3. Endocrinology & Diabetes, Counties Manukau, Auckland, New Zealand
  4. Women's Health, Middlemore Hospital, Auckland, New Zealand

Gastroparesis is defined as the presence of symptoms associated with delayed gastric emptying in the absence of mechanical obstruction and is recognised as a potential neuropathic complication of long-standing diabetes mellitus (DM), especially in those with type 1 DM, additional diabetes-related complications and poor glycaemic control.

Gastroparesis is more prevalent in women, particularly in those of childbearing age. The cardinal symptoms of nausea, vomiting, bloating, and early satiety are also common during pregnancy. Therefore, recognising this complication can be challenging. The diagnosis and management of gastroparesis during pregnancy must consider the necessity for investigations and treatments that are safe for the fetus. Clear safety data and optimal management protocols are lacking. Deterioration in diabetic neuropathies and vasculopathy has been associated with both chronic hyperglycaemia and rapid glycaemic improvement. These mechanisms may contribute to alterations in gastric motility and gastroparesis in pregnancy, particularly in vulnerable women with poor glycaemic control at baseline.

We present a 36-year-old pregnant person with severe gastroparesis in pregnancy, occurring on a background of chronic hyperglycaemia and in the setting of rapid glycaemic improvement following the commencement of basal-bolus insulin therapy. She presented at 32 weeks gestation with intractable vomiting, significant weight loss and constipation. The management was complex, with symptoms that did not respond to multiple antiemetics and prokinetic agents. She experienced severe electrolyte imbalances and intrauterine growth restriction. Her treatment required a multi-modal and multidisciplinary approach over a prolonged hospitalisation, including nasojejunal (NJ) feeding, but ultimately contributed to indicated preterm delivery.

Severe gastroparesis can lead to serious fetal and maternal morbidity, such as that described in this case, and at worst, even fetal death. Significant deterioration in maternal psychological well-being may also occur. This case highlights the potential factors that may lead to severe gastroparesis during pregnancy and stresses the importance of maintaining optimal prepregnancy glycaemic control. It also underscores the importance of identifying preexisting gastrointestinal dysmotility and diabetes-related neuropathic complications.

Preconception counselling and a multidisciplinary approach to patients with gastroparesis can improve pregnancy outcomes. The development of consensus guidelines to manage pregnant patients with this complex condition would be valuable, especially for those receiving antenatal care in centres without access to a specialist obstetric medicine service.

  1. Balasubramanian, Gokulakrishnan MD1; Litzenberg, Kevin MD1; Hinton, Alice PhD1; Chakraborty, Subhankar MD1; Conwell, Darwin L. MD, MS1; Krishna, Somashekar G. MD, MPH2. S0478 Gastroparesis Adversely Impacts Pregnancy Outcomes. The American Journal of Gastroenterology 115():p S239, October 2020. | DOI: 10.14309/01.ajg.0000703960.87868.c5
  2. Achong, N., Fagermo, N., Scott, K., & D'emden, M. (2011). Gastroparesis in pregnancy: case report and literature review. Obstetric medicine, 4(1), 30–34. https://doi.org/10.1258/om.2010.10004
  3. Moosavi S, Min YW, Wong M, Rezaie A. Gastroparesis in pregnancy. Am J Obstet Gynecol. 2023 Apr;228(4):382-394. doi: 10.1016/j.ajog.2022.09.002. Epub 2022 Sep 8. PMID: 36088986.
  4. Azzoug S, Chentli F. Microangiopathy and pregnancy. J Pak Med Assoc. 2016 Sep;66(9 Suppl 1):S52-5. PMID: 27582154.
  5. Phan, H., DeReese, A., Day, A. J., & Carvalho, M. (2014). The dual role of domperidone in gastroparesis and lactation. International journal of pharmaceutical compounding, 18(3), 203–207.
  6. Rupani, S. V., Ergen, W. F., Weber, F., & Peter, S. (2018). Direct Percutaneous Endoscopic Jejunostomy for the Management of Gastroparesis in Pregnancy. Obstetrics and gynecology, 131(5), 871–874. https://doi.org/10.1097/AOG.0000000000002583
  7. Magalhães D, Bettencourt-Silva R, Manuel Costa M, Saavedra A, Belo S, Queirós J et al (2016). Diabetic gastroparesis – a pregnancy in jeopard. Poster Presentation 18th European Congress of Endocrinology. Endocrine Abstracts (2016) 41 EP328 | DOI: 10.1530/endoabs.41.EP328
  8. Ohlsson, B. A case report on a patient suffering from recurrent vomiting episodes, whose condition improved markedly during pregnancy and breast feeding. BMC Gastroenterol 6, 28 (2006). https://doi.org/10.1186/1471-230X-6-28
  9. Stainforth-Dubois M, McDonald EG. Treatment-induced neuropathy of diabetes related to abrupt glycemic control. CMAJ. 2021 Jul 19;193(28):E1085-E1088. doi: 10.1503/cmaj.202091. PMID: 34281965; PMCID: PMC8315201.
  10. Halland M, Bharucha AE. Relationship Between Control of Glycemia and Gastric Emptying Disturbances in Diabetes Mellitus. Clin Gastroenterol Hepatol. 2016 Jul;14(7):929-36. doi: 10.1016/j.cgh.2015.11.021. Epub 2015 Dec 21. PMID: 26717862; PMCID: PMC4912904.